- Home
- CDNA vs MFA Comparison
CDNA vs MFA Comparison
Compare CDNA & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MFA
- Stock Information
- Founded
- CDNA 1998
- MFA 1997
- Country
- CDNA United States
- MFA United States
- Employees
- CDNA N/A
- MFA N/A
- Industry
- CDNA Medical Specialities
- MFA Real Estate Investment Trusts
- Sector
- CDNA Health Care
- MFA Real Estate
- Exchange
- CDNA Nasdaq
- MFA Nasdaq
- Market Cap
- CDNA 1.1B
- MFA 1.1B
- IPO Year
- CDNA 2014
- MFA N/A
- Fundamental
- Price
- CDNA $23.16
- MFA $10.60
- Analyst Decision
- CDNA Buy
- MFA Buy
- Analyst Count
- CDNA 8
- MFA 5
- Target Price
- CDNA $26.43
- MFA $13.50
- AVG Volume (30 Days)
- CDNA 823.5K
- MFA 929.4K
- Earning Date
- CDNA 02-26-2025
- MFA 02-19-2025
- Dividend Yield
- CDNA N/A
- MFA 13.26%
- EPS Growth
- CDNA N/A
- MFA N/A
- EPS
- CDNA N/A
- MFA 1.60
- Revenue
- CDNA $312,775,000.00
- MFA $366,192,000.00
- Revenue This Year
- CDNA $20.27
- MFA N/A
- Revenue Next Year
- CDNA $11.76
- MFA $14.93
- P/E Ratio
- CDNA N/A
- MFA $6.60
- Revenue Growth
- CDNA 5.26
- MFA 164.50
- 52 Week Low
- CDNA $7.42
- MFA $9.36
- 52 Week High
- CDNA $34.84
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- CDNA 47.43
- MFA 56.59
- Support Level
- CDNA $22.50
- MFA $10.06
- Resistance Level
- CDNA $23.81
- MFA $10.57
- Average True Range (ATR)
- CDNA 1.21
- MFA 0.19
- MACD
- CDNA 0.03
- MFA 0.08
- Stochastic Oscillator
- CDNA 49.08
- MFA 92.91
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.